Weitz & Luxenberg has achieved a $13.34 million judgment on a behalf of a victim who was viciously attacked at a bar in Queens, New…Read More
W&L Now Accepting Essure Birth Control Injury and Death CasesMar. 28, 2016
Weitz & Luxenberg is now accepting cases involving injuries from the nonsurgical permanent birth control device Essure. After implantation, a woman visits her physician three months later for a follow-up exam to confirm device placement.
The law firm is interested in talking to those implanted with Essure devices who went to their follow-up doctor visit, but still suffered severe and persistent bleeding or pain so extreme that surgery, such as hysterectomy or bilateral salpingo-oophorectomy (removal of the fallopian tubes and ovaries), was required.
W&L also is interested in hearing from women who have been implanted with the Essure devices who have been informed that they will need such surgery due to complications with the devices.
We would also like to hear from women who have had the Essure devices implanted who already had or may need to undergo surgery as a result of the device breaking or moving, or perforating other tissues.
Surviving family members of a loved one who died due to problems with Essure are also invited to contact W&L to explore their legal rights against the manufacturer.
Essure has also been accused of contributing to fetal birth defects. Parents of those young victims are also invited to contact W&L.
Essure Birth Control Sold for More Than a Decade
The New York Times reports that it is estimated approximately three quarters of a million women have received an Essure implant in the approximately 14 years since the U.S. Food and Drug Administration (FDA) approved the device.
An Essure implant consists of two nickel-titanium and polyester coils. The device’s intended use is via insertion into the entrance of both of a woman’s fallopian tubes, through the uterus. There, they are supposed to encourage scar tissue to form.
This scarring is supposed to block the fallopian tubes, stopping sperm from fertilizing a woman’s eggs. However, The Times reported the FDA has received thousands of reports from women and physicians about severe pelvic pain and bleeding and other problems.
The FDA announced in February it had drafted a boxed warning it intends to require be added to Essure’s label, warning of perforation of the uterus or fallopian tubes, migration of the devices to other tissues, and persistent pain, some of which required surgery. A boxed warning is the most serious type of alert, The Times noted.
W&L Offers a No-Cost, No-Obligation Consultation
Many women injured by or simply concerned about the risks of Essure use have been pressing the FDA to order a recall, The Times said. The agency has not decided to take that step at this time, the newspaper indicated.
The FDA’s reluctance to order an Essure recall led a congressman from Pennsylvania late last year to introduce a bill, called the “E-Free Act,” that seeks to compel market withdrawal of the device.
To schedule a no-cost, no-obligation discussion with a W&L attorney about your legal rights to compensation arising from an Essure injury, please complete and submit the request form that appears on this page or call (800) 476-6070.